These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8432380

  • 41. Rates of production and consumption of phosphatidic acid upon thrombin stimulation of human platelets.
    Tysnes OB, Verhoeven AJ, Holmsen H.
    Eur J Biochem; 1988 May 16; 174(1):75-9. PubMed ID: 3371366
    [Abstract] [Full Text] [Related]

  • 42. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun 16; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 43. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM, Limbird LE.
    Proc Natl Acad Sci U S A; 1983 Sep 16; 80(17):5320-4. PubMed ID: 6577431
    [Abstract] [Full Text] [Related]

  • 44. Phosphoinositide breakdown as an indirect link between stimulation and aggregation of rat platelets by thrombin and collagen.
    Kito M, Narita H, Ishinaga M, Park HJ, Takamura H.
    J Biochem; 1985 Mar 16; 97(3):765-72. PubMed ID: 2991207
    [Abstract] [Full Text] [Related]

  • 45. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

  • 46. Phospholipid metabolism in platelets from stroke-prone spontaneously hypertensive rats and Wistar Kyoto rats.
    Ikeda M, Onda T, Mitsubori T, Umegaki K, Tomita I, Tomita T.
    J Pharmacobiodyn; 1992 Feb 01; 15(2):49-57. PubMed ID: 1328596
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Effects of latamoxef on in vitro and ex vivo thromboxane A2 generation in human platelets.
    Mihara S, Kakushi H, Shike T, Uchida K, Maruyama T, Okabayashi T, Inoue T, Shirai D, Takeda Y, Hara H.
    Thromb Res; 1988 Jan 15; 49(2):215-24. PubMed ID: 3129816
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Protein phosphorylation and diglyceride production during serotonin release induced by epinephrine plus ADP in human platelets.
    Kawahara Y, Yamanishi J, Tsunemitsu M, Fukuzaki H.
    Thromb Res; 1983 Jun 01; 30(5):477-85. PubMed ID: 6612681
    [Abstract] [Full Text] [Related]

  • 53. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D, Gear A.
    Thromb Res; 2007 Jun 01; 120(6):885-92. PubMed ID: 17306868
    [Abstract] [Full Text] [Related]

  • 54. Effects of trifluoperazine on platelet activation.
    Ardlie NG, Boatwright C, Garrett J, McGuiness JA.
    Thromb Res; 1985 Jun 15; 38(6):695-706. PubMed ID: 3161211
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 15; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 57. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K, Lange D, Presek P.
    Thromb Haemost; 2004 Jul 15; 92(1):114-23. PubMed ID: 15213852
    [Abstract] [Full Text] [Related]

  • 58. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI.
    Am J Hematol; 1984 May 15; 16(4):335-45. PubMed ID: 6326566
    [Abstract] [Full Text] [Related]

  • 59. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):37-43. PubMed ID: 16313903
    [Abstract] [Full Text] [Related]

  • 60. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M, Le Couedic JP, Vargaftig BB, Benveniste J.
    Br J Haematol; 1980 Nov 19; 46(3):455-64. PubMed ID: 6778498
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.